相关实验视频
Updated: Jun 18, 2025
10:43
Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
Published on: December 23, 2022
3.3K
由新辅助化学放射治疗驱动的食道状细胞癌中基因组和免疫基因组的演变
Zelin Weng1, Zihang Mai2,3, Jianye Yuan2,3,4
1State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
International journal of cancer
|July 31, 2024
概括
新辅助化学放射疗法 (NCRT) 形成食道状细胞癌 (ESCC) 的演变. 两个不同的克隆动态,灭绝和持久性,预测患者的预后和NCRT后的免疫反应.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 免疫学 免疫学 免疫学
背景情况:
- 术后的新辅助化疗放射治疗 (NCRT) 是局部晚期食道状细胞癌 (ESCC) 的标准治疗方法.
- 了解NCRT后ESCC中的基因组和免疫基因组演变至关重要,但不完整.
研究的目的:
- 为了研究ESCC瘤的基因组和免疫基因组变化,用NCRT治疗.
- 识别不同的克隆动态模式及其与患者预后和免疫微环境的相关性.
主要方法:
- 51个ESCC瘤 (NCRT前后) 的整体外组测序.
- 36个ESCC瘤的转录基因组测序.
- 克隆分析以确定灭绝和持久性模式.
- 对基因组内异质性,新抗原和免疫透的分析.
主要成果:
- 确定了两个克隆动态:灭绝 (所有NCRT前的克隆都消失了) 和持久性 (克隆仍然存在).
- 克隆持续性患者在NCRT前异质性较高,预后更差.
- 克隆灭绝的患者在NCRT后表现出免疫透和T细胞受体-新抗原相互作用的增加.
结论:
- 在ESCC中,NCRT驱动着不同的克隆动态模式 (灭绝与持久),影响预后.
- 这些动态与瘤免疫微环境的显著变化有关.
- 这些发现增强了对NCRT下的ESCC演变的理解.
相关概念视频
01:03Rous Sarcoma Virus (RSV) and Cancer
5.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.0K
01:27Tumor Immunotherapy
498
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
498
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K